EGFR tyrosine kinase inhibitors (TKIs) are effective treatments for EGFR-mutant non-small cell lung cancer (NSCLC). However, ...

It was in many ways something of a coincidence that this technology should end up as a lung cancer medication. Originally, the research team was working to identify a method that would deliver drugs ...

When Ed O. went to the ER for shortness of breath and trembling, he never imagined he’d receive a diagnosis of unresectable ...

The survival rate for people with lung cancer is improving, according to the new State of Lung Cancer report. The American ...

Louisiana residents have one of the highest lung cancer death rates in the country, even as groundbreaking treatments in ...

In a study led by researchers at the NUS Yong Loo Lin School of Medicine, extracellular vesicles loaded with customizable ...

Two kinase inhibitors have been recommended by the European Medicines Agency for the treatment of non-small cell lung cancer.

A new report from the American Lung Association reveals both progress and persistent challenges in the fight against lung ...

CURE® spoke with a lung cancer treatment expert about study findings showing survival benefits with the addition of ...

American Lung Association’s ‘State of Lung Cancer’ report reveals stark differences in survival, screening and treatment across states ...

Alabama ranks near the bottom of the nation for lung cancer survival, with just over one-fifth of diagnosed patients ...

The latest report by the American Lung Association also found marked state-by-state and racial differences related to ...